Vanda Pharmaceuticals (VNDA) Financials: Revenue & Earnings
$232.78M
Market Cap
—
P/E
—
Forward P/E
—
Score
VNDA price $3.85 -0.14 -3.51%
VNDA fair value $16.91. Price $3.85. Price is 77% below fair value.
Below fair value, and cheaper than usual. A larger discount than on more than 99% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 42.74M. Growth 15.16%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 60.46M. Net debt -72.23M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-10-28 | — | -0.68 | — | 69.20M |
| 2026-08-05 | -1.04 | -0.58 | 50.53M | 61.92M |
| 2026-05-06 | -0.82 | -0.53 | 51.72M | 54.98M |
| 2026-02-11 | -2.39 | -2.18 | 57.22M | 59.27M |
| 2025-10-29 | -0.38 | -0.31 | 56.26M | 59.27M |
| 2025-07-31 | -0.46 | -0.34 | 52.59M | 58.73M |
| 2025-05-07 | -0.50 | -0.55 | 50.04M | 45.13M |
| 2025-02-13 | -0.08 | -0.14 | 53.19M | 52.25M |
| 2024-11-06 | -0.09 | -0.17 | 47.65M | 49.15M |
| 2024-07-31 | -0.08 | -0.21 | 50.47M | 50.73M |
| 2024-05-08 | -0.07 | 0.05 | 47.46M | 48.50M |
| 2024-02-07 | -0.04 | -0.09 | 45.27M | 37.00M |
| 2023-11-08 | 0.00 | 0.00 | 38.81M | 44.50M |
| 2023-07-27 | 0.03 | -0.13 | 46.06M | 50.50M |
| 2023-05-03 | 0.06 | — | 62.50M | — |
| 2023-02-08 | 0.12 | 0.08 | 64.48M | 67.60M |
| 2022-11-02 | 0.06 | 0.09 | 65.32M | 71.00M |
| 2022-08-03 | 0.05 | 0.11 | 64.39M | 67.00M |
| 2022-05-05 | -0.11 | -0.01 | 60.19M | 58.00M |
| 2022-02-23 | 0.12 | 0.09 | 68.02M | 70.04M |
| 2021-11-03 | 0.14 | 0.18 | 70.09M | 75.00M |
| 2021-07-28 | 0.17 | 0.14 | 67.90M | 75.00M |
| 2021-05-05 | 0.15 | 0.15 | 62.67M | 68.50M |
| 2021-02-10 | 0.15 | 0.14 | 67.65M | 62.82M |
| 2020-10-28 | 0.11 | 0.10 | 60.31M | 163.43M |
| 2020-08-05 | 0.16 | 0.04 | 62.21M | 15.55M |
| 2020-05-06 | 0.01 | 0.00 | 58.00M | — |
| 2020-02-25 | 0.08 | 0.11 | 60.93M | 83.78M |
| 2019-11-06 | 1.84 | 0.07 | 59.48M | 2.26M |
| 2019-07-31 | 0.21 | 0.00 | 59.06M | — |
| 2019-05-01 | 0.06 | 0.06 | 47.71M | 333.99M |
| 2019-02-13 | 0.19 | 0.13 | 53.04M | 2.79M |
| 2018-11-07 | 0.20 | 0.03 | 49.13M | 11.34M |
| 2018-08-01 | 0.14 | 0.06 | 47.35M | 94.70M |
| 2018-05-02 | 0.14 | -0.05 | 43.59M | 123.51M |
| 2018-02-14 | -0.04 | -0.12 | 44.28M | 132.83M |
| 2017-11-07 | -0.10 | -0.10 | 41.34M | 45.47M |
| 2017-08-02 | -0.03 | -0.21 | 42.06M | 392.52M |
| 2017-05-02 | -0.17 | -0.13 | 37.41M | 41.82M |
| 2017-02-15 | -0.01 | -0.09 | 38.24M | 344.20M |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-04 | McGuire Daniel Patrick | Buy | 80.00K | — | — |
| 2026-06-04 | Chrousos Phaedra | Buy | 41.60K | — | — |
| 2026-06-04 | Duncan Charles Cliff | Buy | 41.60K | — | — |
| 2026-06-04 | DUGAN RICHARD W | Buy | 41.60K | — | — |
| 2026-06-04 | Ward Anne Sempowski | Buy | 41.60K | — | — |
| 2026-06-04 | Honore Tage | Buy | 41.60K | — | — |
| 2026-06-04 | Mitchell Stephen Ray | Buy | 41.60K | — | — |
| 2026-06-04 | McGuire Daniel Patrick | Other | 0 | — | — |
| 2026-06-04 | McGuire Daniel Patrick | Other | 0 | — | — |
| 2026-06-04 | McGuire Daniel Patrick | Other | 0 | — | — |
| 2026-06-04 | McGuire Daniel Patrick | Other | 0 | — | — |
| 2026-05-18 | Mitchell Stephen Ray | Sell | 25.84K | — | — |
| 2026-04-22 | Duncan Charles Cliff | Buy | 57.10K | — | — |
| 2026-04-22 | Duncan Charles Cliff | Other | 0 | — | — |
| 2026-04-01 | Polymeropoulos Christos Vasilios Mihael | Other | 0 | — | — |
| 2026-04-01 | Polymeropoulos Christos Vasilios Mihael | Other | 0 | — | — |
| 2026-04-01 | Polymeropoulos Christos Vasilios Mihael | Other | 0 | — | — |
| 2026-04-01 | Polymeropoulos Christos Vasilios Mihael | Other | 0 | — | — |
| 2026-04-01 | Polymeropoulos Christos Vasilios Mihael | Other | 0 | — | — |
| 2026-04-01 | Polymeropoulos Christos Vasilios Mihael | Other | 61.20K | $7.05 | 431.46K |
| 2026-04-01 | Howell Scott Laverne | Other | 0 | — | — |
| 2026-04-01 | Howell Scott Laverne | Other | 0 | — | — |
| 2026-04-01 | Howell Scott Laverne | Other | 0 | — | — |
| 2026-04-01 | Howell Scott Laverne | Other | 0 | — | — |
| 2026-04-01 | Howell Scott Laverne | Other | 0 | — | — |
| 2026-04-01 | Howell Scott Laverne | Other | 0 | — | — |
| 2026-04-01 | Howell Scott Laverne | Other | 77.50K | $7.05 | 546.38K |
| 2026-04-01 | Howell Scott Laverne | Other | 61.20K | $11.36 | 695.23K |
| 2026-04-01 | Howell Scott Laverne | Other | 28.60K | $20.28 | 580.01K |
| 2026-04-01 | Howell Scott Laverne | Other | 25.00K | $11.32 | 283.00K |
| 2026-03-02 | Williams Timothy | Sell | 42.43K | $8.27 | 350.76K |
| 2026-03-02 | Moran Kevin Patrick | Sell | 42.44K | $8.27 | 350.82K |
| 2026-03-02 | Wijkstrom Joakim | Sell | 30.80K | $8.27 | 254.59K |
| 2026-03-02 | Polymeropoulos Mihael Hristos | Sell | 156.24K | $8.17 | 1.28M |
| 2026-03-02 | Birznieks Gunther | Sell | 42.43K | $8.27 | 350.73K |
| 2026-02-23 | Honore Tage | Sell | 30.00K | $8.03 | 240.90K |
| 2026-02-18 | Wijkstrom Joakim | Buy | 125.00K | — | — |
| 2026-02-18 | Birznieks Gunther | Buy | 125.00K | — | — |
| 2026-02-18 | Williams Timothy | Buy | 125.00K | — | — |
| 2026-02-18 | Moran Kevin Patrick | Buy | 125.00K | — | — |
| 2026-02-18 | Polymeropoulos Mihael Hristos | Buy | 525.00K | — | — |
| 2025-08-07 | Polymeropoulos Mihael Hristos | Buy | 10.00K | $4.15 | 41.50K |
| 2025-06-13 | Mitchell Stephen Ray | Sell | 7.00K | $4.59 | 32.13K |
| 2025-06-05 | Mitchell Stephen Ray | Buy | 59.23K | — | — |
| 2025-06-05 | Chrousos Phaedra | Buy | 59.23K | — | — |
| 2025-06-05 | DUGAN RICHARD W | Buy | 59.23K | — | — |
| 2025-06-05 | Honore Tage | Buy | 59.23K | — | — |
| 2025-06-05 | Ward Anne Sempowski | Buy | 59.23K | — | — |
| 2025-05-21 | Polymeropoulos Mihael Hristos | Buy | 481 | $4.39 | 2.11K |
| 2025-05-21 | Polymeropoulos Mihael Hristos | Buy | 9.52K | $4.40 | 41.88K |
| 2025-05-16 | Polymeropoulos Mihael Hristos | Buy | 20.00K | $4.22 | 84.47K |
| 2025-03-06 | Polymeropoulos Mihael Hristos | Buy | 5.00K | $5.01 | 25.05K |
| 2025-03-06 | Polymeropoulos Mihael Hristos | Buy | 5.00K | $5.02 | 25.10K |
| 2025-03-05 | Polymeropoulos Mihael Hristos | Buy | 5.00K | $5.03 | 25.15K |
| 2025-03-05 | Polymeropoulos Mihael Hristos | Buy | 5.00K | $5.01 | 25.05K |
| 2025-03-03 | Polymeropoulos Mihael Hristos | Buy | 10.00K | $4.71 | 47.05K |
| 2025-03-01 | Wijkstrom Joakim | Sell | 15.52K | $4.76 | 73.88K |
| 2025-03-01 | Birznieks Gunther | Sell | 26.94K | $4.76 | 128.24K |
| 2025-03-01 | Polymeropoulos Mihael Hristos | Sell | 96.00K | $4.76 | 456.96K |
| 2025-03-01 | Moran Kevin Patrick | Sell | 26.94K | $4.76 | 128.24K |
| 2025-03-01 | Williams Timothy | Sell | 26.94K | $4.76 | 128.24K |
| 2025-02-28 | Polymeropoulos Mihael Hristos | Buy | 10.00K | $4.76 | 47.60K |
| 2025-02-27 | Polymeropoulos Mihael Hristos | Buy | 10.00K | $4.76 | 47.60K |
| 2025-02-26 | Polymeropoulos Mihael Hristos | Buy | 5.00K | $4.78 | 23.90K |
| 2025-02-26 | Polymeropoulos Mihael Hristos | Buy | 5.00K | $4.75 | 23.75K |
| 2025-02-25 | Polymeropoulos Mihael Hristos | Buy | 10.00K | $4.46 | 44.64K |
| 2025-02-21 | Moran Kevin Patrick | Buy | 2.00K | $4.39 | 8.78K |
| 2025-02-18 | Wijkstrom Joakim | Buy | 125.00K | — | — |
| 2025-02-18 | Polymeropoulos Mihael Hristos | Buy | 450.00K | — | — |
| 2025-02-18 | Moran Kevin Patrick | Buy | 125.00K | — | — |
| 2025-02-18 | Birznieks Gunther | Buy | 125.00K | — | — |
| 2025-02-18 | Williams Timothy | Buy | 125.00K | — | — |
| 2024-11-14 | Mitchell Stephen Ray | Sell | 5.00K | $5.17 | 25.86K |
| 2024-07-29 | Moran Kevin Patrick | Sell | 2.25K | $5.92 | 13.33K |
| 2024-05-22 | Chrousos Phaedra | Buy | 21.89K | — | — |
| 2024-05-22 | Chrousos Phaedra | Buy | 40.20K | $5.14 | 206.64K |
| 2024-05-17 | Honore Tage | Buy | 20.53K | — | — |
| 2024-05-17 | Honore Tage | Buy | 37.58K | $5.48 | 205.93K |
| 2024-05-17 | DUGAN RICHARD W | Buy | 20.53K | — | — |
| 2024-05-17 | DUGAN RICHARD W | Buy | 37.58K | $5.48 | 205.93K |
| 2024-05-17 | Mitchell Stephen Ray | Buy | 20.53K | — | — |
| 2024-05-17 | Mitchell Stephen Ray | Buy | 37.58K | $5.48 | 205.93K |
| 2024-05-17 | Ward Anne Sempowski | Buy | 20.53K | — | — |
| 2024-05-17 | Ward Anne Sempowski | Buy | 37.58K | $5.48 | 205.93K |
| 2024-03-05 | Williams Timothy | Sell | 8.94K | $4.18 | 37.40K |
| 2024-03-05 | Wijkstrom Joakim | Sell | 9.23K | $4.21 | 38.83K |
| 2024-03-05 | Polymeropoulos Mihael Hristos | Sell | 24.29K | $4.13 | 100.27K |
| 2024-03-05 | Moran Kevin Patrick | Sell | 8.90K | $4.20 | 37.41K |
| 2024-03-05 | Birznieks Gunther | Sell | 8.68K | $4.13 | 35.88K |
| 2024-03-04 | Williams Timothy | Sell | 8.15K | $4.41 | 35.92K |
| 2024-03-04 | Wijkstrom Joakim | Sell | 7.50K | $4.41 | 33.09K |
| 2024-03-04 | Polymeropoulos Mihael Hristos | Sell | 30.88K | $4.24 | 131.07K |
| 2024-03-04 | Moran Kevin Patrick | Sell | 5.80K | $4.48 | 25.98K |
| 2024-03-04 | Birznieks Gunther | Sell | 8.73K | $4.30 | 37.49K |
| 2024-02-16 | Williams Timothy | Buy | 125.00K | — | — |
| 2024-02-16 | Wijkstrom Joakim | Buy | 32.70K | — | — |
| 2024-02-16 | Moran Kevin Patrick | Buy | 125.00K | — | — |
| 2024-02-16 | Polymeropoulos Mihael Hristos | Buy | 450.00K | — | — |
| 2024-02-16 | Birznieks Gunther | Buy | 125.00K | — | — |
| 2023-08-21 | Wijkstrom Joakim | Sell | 3.72K | $5.84 | 21.75K |
Latest filed quarter: Q2 2026.
Institutions holding: 177, holders +2 vs prior quarter. Ownership 83.57%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 7.65M | 377.75K | +5.19% | 46.84M |
| STATE STREET CORP | 3.52M | 500.84K | +16.61% | 21.52M |
| AQR CAPITAL MANAGEMENT LLC | 3.50M | 1.89M | +118.12% | 21.41M |
| RENAISSANCE TECHNOLOGIES LLC | 3.44M | -318.20K | -8.46% | 21.06M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.52M | 42.55K | +1.71% | 15.45M |
| AIGH CAPITAL MANAGEMENT LLC | 2.04M | -705.83K | -25.67% | 12.51M |
| ACADIAN ASSET MANAGEMENT LLC | 1.92M | 122.47K | +6.82% | 11.73M |
| DIMENSIONAL FUND ADVISORS LP | 1.73M | -44.24K | -2.50% | 10.57M |
| MILLENNIUM MANAGEMENT LLC | 1.60M | -278.19K | -14.79% | 9.81M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.48M | 40.82K | +2.83% | 9.08M |
| TWO SIGMA INVESTMENTS, LP | 1.35M | -49.13K | -3.51% | 8.26M |
| MARSHALL WACE, LLP | 1.23M | 629.99K | +105.70% | 7.50M |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.21M | 44.65K | +3.82% | 7.43M |
| KRENSAVAGE ASSET MANAGEMENT, LLC | 1.18M | 0 | 0.00% | 7.22M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.13M | 116.51K | +11.48% | 6.92M |
| GOLDMAN SACHS GROUP INC | 1.04M | 198.03K | +23.62% | 6.34M |
| CITADEL ADVISORS LLC | 758.30K | 697.80K | +1153.39% | 4.64M |
| QUBE RESEARCH & TECHNOLOGIES LTD | 729.21K | 729.21K | New | 4.46M |
| FEDERATED HERMES, INC. | 714.28K | 138.89K | +24.14% | 4.37M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 646.26K | 646.26K | New | 3.96M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 646.26K | 94.49K | +17.12% | 3.96M |
| NORTHERN TRUST CORP | 600.62K | 149.64K | +33.18% | 3.68M |
| MORGAN STANLEY | 477.97K | 37.18K | +8.43% | 2.93M |
| LIONHUNTER CAPITAL MANAGEMENT, LLC | 400.25K | 400.25K | New | 2.45M |
| VANGUARD FIDUCIARY TRUST CO | 399.82K | 11.85K | +3.06% | 2.45M |
Vanda Pharmaceuticals Inc. (VNDA) trades at $3.85, with a market cap of $232.78M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn
$232.78M
Market Cap
—
P/E
—
Forward P/E
—
Score